Answers are grounded in this paper and cite their sources.
Background & Objective: Due to the severe inflammatory conditions and cytokine storm in COVID-19 disease, corticosteroids are used worldwide as adjunctive therapy for these patients due to their anti-inflammatory effects. However, due to limited and inconsistent information about the effectiveness of this drug, this study aimed to investigate the benefit of combined use of -interferon and methylprednisolone in patients with COVID-19.
No takes yet. Share an insight, caveat, or question.
Razavi et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: